Sign inJoin waitlistJoin the waitlist

Oleksandra Lupak

Associate Professor, Hematology & Oncology · Medical University of South Carolina College of Medicine

Credentials: · · · · · · ·

History

Medical University of South Carolina College of Medicine
Present

Hematology and Medical Oncology
Henry Ford Health
2017–2020
Internal Medicine
Henry Ford Hospital
2014–2017
College of Medicine
2010–2014

Research

Socioeconomic and Racial Disparities: a Case-Control Study of Patients Receiving Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
Journal of Racial and Ethnic Health Disparities · 2017 · 71 citations
The role of a low erythropoietin level for the polycythemia vera diagnosis
Blood cells · 2020 · First of 6 authors · Corresponding · 27 citations
Demographic differences among patients treated with chimeric antigen receptor T-cell therapy in the United States
Cancer Medicine · 2022 · 27 citations

JE
Josephine Emole
3 papers
OL
Odunayo Lawal
2 papers
PX
Peter Xie
2 papers · 2 as a fellow
AD
Ajoy Dias
1 paper
Anna Stone
1 paper · 1 as a fellow
BG
Bolanle Gbadamosi
1 paper · 1 as a fellow
Chetan Mittal
1 paper · 1 as a fellow
Daniel Ezekwudo
1 paper · 1 as a fellow
HM
Hadi Mohammed
1 paper · 1 as a fellow
Hemalatha Rangarajan
1 paper
HJ
Hiba Jabbour-Aida
1 paper · 1 as a fellow
II
Iyad Isseh
1 paper · 1 as a fellow

Clinical trials

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2025–2029
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027